A Pan-RNase Inhibitor Enabling CRISPR-mRNA Platforms for Engineering of Primary Human Monocytes.
A Pan-RNase Inhibitor Enabling CRISPR-mRNA Platforms for Engineering of Primary Human Monocytes.
复制标题
一种泛RNA酶抑制剂,使CRISPR-mRNA平台能够用于原代人单核细胞的工程化。
DOI:
10.3390/ijms23179749
复制
发表时间:
2022-08-28
影响因子:
5.6
通讯作者:
中科院分区:
文献类型:
--
作者:
Monocytes and their downstream effectors are critical components of the innate immune system. Monocytes are equipped with chemokine receptors, allowing them to migrate to various tissues, where they can differentiate into macrophage and dendritic cell subsets and participate in tissue homeostasis, infection, autoimmune disease, and cancer. Enabling genome engineering in monocytes and their effector cells will facilitate a myriad of applications for basic and translational research. Here, we demonstrate that CRISPR-Cas9 RNPs can be used for efficient gene knockout in primary human monocytes. In addition, we demonstrate that intracellular RNases are likely responsible for poor and heterogenous mRNA expression as incorporation of pan-RNase inhibitor allows efficient genome engineering following mRNA-based delivery of Cas9 and base editor enzymes. Moreover, we demonstrate that CRISPR-Cas9 combined with an rAAV vector DNA donor template mediates site-specific insertion and expression of a transgene in primary human monocytes. Finally, we demonstrate that SIRPa knock-out monocyte-derived macrophages have enhanced activity against cancer cells, highlighting the potential for application in cellular immunotherapies.
登录
查看更多内容
影响因子:
46.9
作者:
Hendel A;Bak RO;Clark JT;Kennedy AB;Ryan DE;Roy S;Steinfeld I;Lunstad BD;Kaiser RJ;Wilkens AB;Bacchetta R;Tsalenko A;Dellinger D;Bruhn L;Porteus MH
通讯作者:
Porteus MH
DOI:
10.1073/pnas.0809422106
发表时间:
2009-04-14
影响因子:
11.1
作者:
Huang, Xin;Venet, Fabienne;Ayala, Alfred
通讯作者:
Ayala, Alfred
影响因子:
5.4
作者:
CHALLITA, PM;SKELTON, D;KOHN, DB
通讯作者:
KOHN, DB
影响因子:
46.9
作者:
Klichinsky M;Ruella M;Shestova O;Lu XM;Best A;Zeeman M;Schmierer M;Gabrusiewicz K;Anderson NR;Petty NE;Cummins KD;Shen F;Shan X;Veliz K;Blouch K;Yashiro-Ohtani Y;Kenderian SS;Kim MY;O'Connor RS;Wallace SR;Kozlowski MS;Marchione DM;Shestov M;Garcia BA;June CH;Gill S
通讯作者:
Gill S
影响因子:
14.9
作者:
Brinkman EK;Chen T;Amendola M;van Steensel B
通讯作者:
van Steensel B